Skip to main content
. 2021 Jun;35(11-12):870–887. doi: 10.1101/gad.348316.121

Figure 1.

Figure 1.

Whole genome CRISPR/Cas9 screen identifies potential therapeutic targets and pathways in SCLC (A) Schematic of the CRISPR/Cas9 dropout screen conducted using the GeCKO v2 lentiviral mouse library. (B,C) Volcano plots of MAGeCK analysis results from five screened mSCLC cell lines (B) and three screened Trp53-null MEF isolates (C). (D) CRISPR score heat map of the top depleted and enriched genes for each of the five mSCLC cell lines and three Trp53-null MEF isolates screened.